Clinical Analysis Of 15 Cases Of Locally Advanced Esophageal Cancer

BackgroundEsophageal cancer is a common malignant tumor of the digestive tract.The characteristics of the onset of occult cancer cause the majority of patients to be diagnosed mostly in the middle and late stages,and their prognosis is poor.With the advancement of medicine,there are new therapeutic concepts proposed such as neoadjuvant chemoradiation,and the 5-year survival rate is still only 20%-40%.Most scholars find that surgical treatment is still the best way to benefit patients with esophageal cancer.Therefore,some scholars have proposed that the aim of the treatment of esophageal cancer should be to improve the quality of life of patients.However,some patients with esophageal cancer have been treated with non-surgical treatment because of their long tumors,resulting in extremely low efficacy.In this experimental group,15 patients with esophageal cancer with a tumor length of more than 8 cm were collected and thoracoscopic surgery was performed to improve three incision surgeries and selective lymph node dissection.The effect of aggressive surgery on esophageal cancer with a tumor length of more than 8 cm was investigated.Research purposesThrough 15 cases of esophageal cancer patients over 8 cm in length undergoing active surgical treatment,analysis of perioperative complications,postoperative quality of life,etc.,to explore the impact of tumor length on surgical resection rate and evaluation of aggressive surgery in tumor length more than 8 cm Value in patients with esophageal cancer.Research methodsFrom January 2010 to December 2017,15 patients with esophageal cancer were treated in our department.Age 46 to 78 years old,average 60.3 years old,male to female ratio 2:1,are middle-stage esophageal cancer patients.8 cases(53.3%)were tumors longer than 8 cm,3 cases(20%)more than 10 cm,3 cases(20%)more than 12 cm,and 1 case(6.7%)more than 15 cm.All patients underwent thoracoscope-assisted three-incision surgery,selective lymph node dissection,and complete resection of esophageal tumors.Postoperative pathology confirmed that there were no cancerous cells at the margin.Perioperative complications,postoperative life quality assessment,and follow-up results were used to evaluate the efficacy of the treatment.Research resultPerioperative complications and postoperative quality of life were rated higher.One case was lost to follow-up one year after surgery.One patient had a tumor length of 15.5 cm and survived for more than five years after surgery.The postoperative quality of life score was higher.He died of liver cancer metastasis.Three patients were followed up for 4 years without recurrence.In metastasis,3 patients had no recurrence and metastasis after 3 years of follow-up,2 patients had no recurrence and metastasis after follow-up for 2 years,1 had no recurrence and metastasis 1 year after surgery,and 1 patient died of severe pneumonia one year after surgery.1 One year after surgery died of cachexia.All patients were not complicated with esophageal-related diseases such as esophageal tracheal fistula,esophageal aortic spasm,and no postoperative eating difficulties.Analysis conclusionThe length of the tumor does not affect the surgical resection rate of patients with esophageal cancer,and surgical treatment can effectively improve the quality of life of patients.